胡锡进A

Source: Global Times
【Global Times Science and Technology Comprehensive Report】On August 25, a latest report from Androidauthority indicated that Samsung’s next-generation flagship Galaxy S27 Ultra is expected to introduce a highly practical new feature. The new device will come with special glass with self-healing capabilities that can automatically complete repair filling for minor scratches on the device’s surface.
This weekend, industry observer Schr?dinger disclosed on a social platform that Samsung is jointly developing a brand-new self-healing surface coating with Corning. This technology will be applied to the next-generation Gorilla Armor gorilla armor glass. Based on current technical specifications, the glass with a self-healing coating is temporarily not as good as conventional tempered glass in terms of initial scratch resistance. However, thanks to its ability to automatically fill in tiny scratches, the improvement in long-term user experience is enough to offset the impact of that performance trade-off.

August 25 news, according to information from the China National Intellectual Property Administration, Ningxia Orient Tantalum Industry Co., Ltd. has applied for a patent titled “Nb Rod with φ50mm~160mm for Nuclear Fusion and Preparation Method.” The publication number is CN122599105A, the application number is CN202610557806.3, the publication date is August 18, 2026, and the application date is April 24, 2026. Inventors include Xie Xinpu, Wang Dongxin, Li Zhaobo, Zhou Xiaojun, Zhang Jiuhai, Dong Wenbiao, Ma Xiaoxiang, and Liu Tingting. The patent agency is Ningxia Sanyuanxin Intellectual Property Agency Partnership (General Partnership), and the patent agent is Yang Li. Classification numbers are G21B1/11 and C22F1/18.

【Reports say Samsung and Corning are developing self-healing glass, Galaxy S27 Ultra may feature it】Samsung Galaxy S27 Ultra may use self-healing glass that can automatically fill in minor scratches. According to reports, Corning and Samsung are jointly developing a new self-healing coating, planned for use in the next-generation Gorilla Armor glass. While this isn’t a brand-new concept, the technology has improved, and it is expected to be released in early 2027. #SamsungGalaxyS27Ultra#

August 24 news: Information from the China National Intellectual Property Administration shows that Dalian Huarui Heavy Industry Hoisting Machinery Co., Ltd. and Dalian Huarui Heavy Industry Group Co., Ltd. have applied for a patent titled “A Gear-End Braking Open Gear Drum Device and Lifting Mechanism.” The application publication number is CN122607926A, the application number is CN202610597070.2, the application publication date is August 21, 2026, and the application date is April 30, 2026. The inventors are Wang Ronggang, Li Shuang, Li Caixia, and Hu Pengyu. The patent agent is Dalian Dongfang Patent Agency Co., Ltd., with patent agent Jiang Yurong. Classification numbers include B66D1/30, B66D1/54, B66D5/14, and B66C13/22.

By Semiconductor Industry Vision Junxi
The story of glass substrates is shifting from “who announces first” to “who can deliver on time.” Entering the second half of 2026, several pieces of news with similar timing but different directions have brought this change into the spotlight: in late July, Intel and Lens Technology (L V S) advanced cooperation on glass substrate packaging for the AI era; on August 11, Korean equipment vendor Avaco and its affiliate AVATEC launched a pilot line for TGV process verification; on August 12, industry-chain reports emerged that Samsung Electro-Mechanics’ sample reliability assessment for customers hit a bottleneck, and the line-building plan for its joint venture GlaSSEM may be delayed, with mass production timing possibly pushed to after 2028.

(Source: Financial News)
At present, the related business of the subsidiaries is still in the early development stage and has not yet formed large-scale revenue.
A shareholder asked Maolai Optics (688502.SH): What product layout does the company have in the field of optical communications? How can the company’s technical capabilities accumulated in optical inspection and nano-level packaging help enable the optical communications sector? Regarding the current industrial bottlenecks in CPO, does the company have product plans for end-to-end inspection equipment? What is the R&D and verification progress of the CPO inspection equipment? Are Corning (GLW.US) and Google Lumentum customers of the company in the optical communications field? What key components does the company provide to domestic and overseas customers in the areas of semiconductor lithography machines and metrology equipment? In light of demand for semiconductor equipment components and the optical communications field, can the company’s production capacity meet the requirements?

According to data from the Center for Drug Evaluation of the National Medical Products Administration, on August 19, 2026, an application for Fukaning Tablets by Jilin Daogun Pharmaceutical Co., Ltd. was accepted. The acceptance number is CYZB2604220.
Acceptance number CYZB2604220; Drug name: Fukaning Tablets; Drug type: Chinese medicine; Application type: Supplementary application for registration; Registration classification; Enterprise name: Jilin Daogun Pharmaceutical Co., Ltd.; Jilin Daogun Pharmaceutical Co., Ltd.; Date of handling: August 19, 2026
According to Tianyancha (a business information platform), Jilin Daogun Pharmaceutical Co., Ltd. was established on January 28, 2002. Its legal representative is Liu Guilan. The company operates in the industry of proprietary Chinese medicine manufacturing. The enterprise type is a joint-stock company (not listed; natural person investment or control). The company is small in size, with 0 insured employees. Registered capital is RMB 30.19 million, and paid-in capital is also RMB 30.19 million. The registered address is No. 140 Fuyuliu, Minying Industrial Park, Baicheng Economic Development Zone. Shareholder information is as follows: Shareholder name | Shareholding percentage | Subscribed capital contribution | Date of subscribed capital contribution | Date of first shareholding; Liu Guilan | 100% | RMB 30.19 million | January 28, 2002 | December 31, 2013

On Tuesday, shares related to the optical communications concept fell broadly. Coherent (COHR.US) plunged 11%, Credo Technology (CRDO.US) dropped more than 9%, Applied Optoelectronics (AAOI.US) fell more than 8%, Mavilor Technology (MRVL.US) slid 7%, Lumentum (LITE.US) dropped more than 6%, POET Technologies (POET.US) and Corning (GLW.US) both fell more than 5%, and Nokia (NOK.US) fell more than 3%.

Data from the Center for Drug Evaluation of the National Medical Products Administration shows that on August 18, 2026, the application for Shen Kang Ning Tablets by Sichuan Tongyuan Pharmaceutical Group Co., Ltd. was accepted. The acceptance number is CYZB2604212.
Acceptance number CYZB2604212
Drug name: Shen Kang Ning Tablets
Drug type: Traditional Chinese medicine
Application type: Supplementary application
Registration category: None
Enterprise name: Sichuan Tongyuan Pharmaceutical Group Co., Ltd.; Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
Handling date: August 18, 2026
Tianyancha data shows that Sichuan Tongyuan Pharmaceutical Group Co., Ltd. was established on February 9, 2002. The legal representative is Hu Dingmin. The industry is the manufacture of chemical pharmaceutical preparations. The company type is a limited liability company (natural person investment or holding). The enterprise size is small. The number of employees covered for insurance is 219. The registered capital is RMB 62 million, and the paid-in capital is RMB 46.39 million. The registered address is No. 33, Section 1, Shenzhen Road West, Guanghan City, Deyang City, Sichuan Province. The shareholder information is as follows: Gao Yulin holds 87.0968% (RMB 54 million) with the subscribed capital date May 31, 2027; first shareholding date February 9, 2002. Feng Shuying holds 12.9032% (RMB 8 million) with the subscribed capital date May 31, 2027; first shareholding date June 30, 2005.

（Source: The Paper）
In Baoshan, the Kangning Road Bridge has been completed for more than 10 years. However, because there were no elevators, residents have long suffered when walking across the bridge—struggling to go up and down. Climbing 66 steps up and then walking down is by no means easy for middle-aged and elderly residents. Now, vertical elevators have been built on both the south and north sides of the bridge. After the equipment is commissioned and debugged, residents will be able to move up and down the bridge with ease.
Kangning Road is a major north-south thoroughfare that connects Baoshan District and the urban center. The Kangning Road Bridge over the Huizao River is an important node. In mid-August this year, some residents noticed that elevators had been built at both the north and south ends of the Kangning Road Bridge. They spread the news far and wide; some even came to the site to watch and try them out, hoping the elevators will be put into use as soon as possible.

On Monday, optical communications concept stocks rose broadly, with Coherent (COHR.US) up more than 7%, Miviel Technology (MRVL.US) up more than 5%, Lumentum (LITE.US) up 5%, Corning (GLW.US) up more than 4%, and Applied Optoelectronics (AAOI.US) up more than 2%.

Editor’s note
　　The old houses with blue brick walls bear the marks of wear and the passage of time, engraving the bustling years of generations; they preserve warm memories of neighbors standing by one another. With new buildings rising from the ground, they place people’s hopes for a better, more livable life and carry a brand-new promise for the city’s iterative upgrades. As urban renewal efforts in Shanghe County move deeper, the reconstruction and renovation work for old residential areas across the jurisdiction has been fully launched. A series of housing projects that take into account cultural preservation, people’s well-being, and urban quality are being implemented in an orderly and solid manner on this fertile land.
　　Before the relocation of the Dongjiu Distillery area, Guo Peizhi and his old neighbors left a group photograph in front of the bungalow homes in the staff quarters. In their smiles were both anticipation and reluctance to say goodbye; today, the old neighbors gather again in the newly built Koningli community. As light and shadow shift, they witness a transformation and upgrade of urban renewal in Shanghe County, and they also tell a heartfelt story of how warmth and care between neighbors endure.

In accordance with the Food Safety Law of the People’s Republic of China and its implementing regulations, and other relevant laws and regulations, the information on the supervisory sampling of edible agricultural products implemented at the district level in Qingjiangpu District for the fourth term of 2026 is hereby announced as follows：
In this round of sampling in Qingjiangpu District, 135 batches of edible agricultural products were inspected, and 1 batch was found to be unqualified (for details of the sampled product information, see the attachment).?
With regard to the unqualified food identified in this supervisory sampling, the Market Supervision and Administration Bureau of Qingjiangpu District has required the local sub-bureaus to order the operating units to ascertain the product flow, recall the unqualified products, analyze the causes for rectification, and investigate and handle the matter according to law.

On Wednesday, U.S. stocks saw broad gains in optical communications concept shares. As of the time of this writing, Ciena (CIEN.US) was up more than 9%, Lumentum (LITE.US) rose more than 6%, Coherent (COHR.US) gained more than 4%, Credo Technology (CRDO.US) was up over 5%, and Mavenir Technology (MRVL.US) and Corning (GLW.US) rose over 5%.

(Source: The Paper)
On the morning of August 10, 2026, heavy short-duration rainfall caused waterlogging on parts of Kanning Road.
During the morning rush hour for people going to work, the on-duty traffic police reached the waterlogging hotspot immediately to direct traffic, guiding residents to slow down, detour, and avoid deep-water areas. They also handled vehicles that had stalled and blocked lanes to ensure roads remained passable.
The duty traffic police arrived at the waterlogging site first. Standing in the water on the scene, they directed traffic flow and guided residents to slow down, detour, and avoid deep-water areas. After vehicles entered the waterlogged road, some stalled and caused lane blockages. The traffic police immediately called for tow trucks to rush to the scene and quickly move the malfunctioning vehicles to a safe area.

?Operation and Finance Network Wu BIhui/By
Around when China Telecom Group’s government and enterprise unit’s Internet industry division’s second department chief was promoted and transferred, he was appointed as deputy general manager of a newly established AIDC company, but his rank remained unchanged—still a third-level senior officer.
Kang Ning had actually been working in the group’s government and enterprise department quite early. In the past, when that department was still called the “Government and Enterprise Customers Business Department,” he served as deputy director of the IDC operation center. That likely explains why he was chosen to take on the role of deputy general manager of the newly established AIDC branch company—he already had a solid track record.
Later, around 2021, Kang Ning received a promotion and was appointed CEO of the second department of the Internet industry business division under the government and enterprise information services business group. His main responsibilities included internet enterprises such as social, media, games, and portals, as well as new infrastructure services like IDC and CDN.

(Source: Xin'an Evening News)
Reprinted from: Xin'an Evening News
Recently, Taikang has been listed in the Fortune 500 for 9 consecutive years and is about to mark its 30th anniversary. Taikang Life has specially launched an upgraded product in the Xinxiang Shijia series—Taikang Xinxiang Shijia 2027 (Yu享 Edition) Whole Life Insurance (Participating) [hereinafter referred to as “Xinxiang Shijia 2027 (Yu享 Edition)”]. The product continues the dual core positioning of “protection + reserve.” Building on fixed step-up growth in the effective sum assured and steady accumulation of cash value, it extends the wealth growth period through a dual-insured design. It is also combined with four dividend payout options and emergency partial surrender rules to provide families with comprehensive solutions encompassing death/total disability protection, long-term wealth accumulation, and targeted inheritance. Meanwhile, relying on two major ecosystems—Happiness with You and Health & Care’s medical-elderly care and wellbeing ecosystem—it provides families with an end-to-end solution spanning wealth accumulation, targeted inheritance, and quality retirement.

On Friday, optical communications concept stocks generally rose. Applied Optoelectronics (AAOI.US) rose more than 12%, Coherent (COHR.US) rose more than 10%, Lumentum (LITE.US) rose more than 6%, POET Technologies (POET.US) rose more than 5%, Corning (GLW.US) rose more than 4%, and Marvell Technology (MRVL.US) rose 4%.
On the news front, on August 6, Applied Optoelectronics released its second-quarter financial results. Revenue was $191.9 million, up 86.4% year over year. Data center business revenue first surpassed $100 million, up 140%. Non-GAAP net profit turned positive. The company also provided third-quarter guidance in the range of $255 million to $290 million, and maintained its full-year revenue target of about $1.1 billion.

Recently, Japanese fiber optic cable supplier Furukawa Electric announced that the company will invest 100 billion yen to expand its fiber optic cable production capacity. It expects to expand the capacity to approximately double the level by the end of fiscal year 2025 to meet the demand from hyperscale data centers for high-quality fiber optic cables. Production is expected to ramp up and be gradually mass-produced starting in the second half of fiscal year 2028.
Furukawa Electric said that demand for “rollable ribbon cables” that are suitable for high-capacity optical transmission remains strong. The current order environment is very favorable, and the company expects demand to further grow in the mid-to-long term. Before making this investment, the company confirmed customer purchase intentions, including long-term procurement commitments.

Data from the National Medical Products Administration (NMPA) Drug Evaluation Center shows that on August 6, 2026, the application for Fukun Ning Tablets by Suzhou Yifan Pharmaceutical Co., Ltd. has been accepted. The acceptance number is CYZB2603938.
Acceptance number CYZB2603938 | Drug name Fukun Ning Tablets | Drug type Chinese medicine | Application type Supplementary application | Registration classification Original Class 9 | Enterprise name Suzhou Yifan Pharmaceutical Co., Ltd.; Suzhou Yifan Pharmaceutical Co., Ltd. | Handling date August 6, 2026
Tianyancha data shows that Suzhou Yifan Pharmaceutical Co., Ltd. was established on March 21, 2013. The legal representative is Tang Yingwu. The industry is the manufacturing of chemical pharmaceutical preparations. The company type is a limited liability company (a wholly state-owned legal entity not invested in or controlled by natural persons). The company size is small, with 247 insured employees. Registered capital is RMB 250 million, and paid-in capital is RMB 200 million. The registered address is the north side of Jinjiang Road, Suzhou Economic Development Zone, Anhui Province. The shareholder information is as follows: Shareholder name | Shareholding ratio | Subscribed capital amount (RMB) | Subscribed capital contribution date | First shareholding date | First shareholding date: Hefei Yifan Biological Pharmaceutical Co., Ltd. | 100% | RMB 250 million | December 31, 2030 | July 10, 2023